×
About 2,893 results

ALLMedicine™ Nephrolithiasis Center

Research & Reviews  1,016 results

An Immune Atlas of Nephrolithiasis: Single-Cell Mass Cytometry on SIRT3 Knockout and Ca...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627562
Journal of Immunology Research; Zhang W, Li L et. al.

Dec 2nd, 2021 - As a common urological disease with a high recurrence rate, nephrolithiasis caused by CaOx may elicit a strong immunologic response. We present a CyTOF-based atlas of the immune landscape in nephrolithiasis models to understand how the immune syst...

European Association of Urology Section of Urolithiasis and International Alliance of U...
https://doi.org/10.1016/j.euf.2021.10.011
European Urology Focus; Zeng G, Zhao Z et. al.

Nov 28th, 2021 - Retrograde intrarenal surgery (RIRS) has become the preferred treatment modality for nephrolithiasis. However, because of ongoing uncertainties regarding the optimal perioperative management, operative technique, and postoperative follow-up, as we...

Cystinuria: an update on pathophysiology, genetics, and clinical management.
https://doi.org/10.1007/s00467-021-05342-y 10.1186/1750-1172-7-19 10.1089/end.2016.0564 10.1016/s0022-5347(05)67633-1 10.1038/ng0494-420 10.1152/physiol.00051.2004 10.1016/j.semnephrol.2008.01.011 10.1016/j.juro.2018.07.047 10.1016/j.kint.2020.06.035 10.1056/NEJM196512022732303 10.1172/JCI105351 10.1097/01.asn.0000029586.17680.e5 10.1038/12652 10.1136/jmg.2004.022244 10.2215/CJN.10981114 10.1038/sj.ejhg.5201894 10.1007/s00240-018-1101-7 10.1016/j.jpurol.2012.08.006 10.1007/s00467-012-2329-z 10.2174/156652408785747997 10.2215/CJN.06680714 10.1016/S0022-5347(05)64824-0 10.1016/j.juro.2016.12.135 10.1007/s00240-019-01110-8 10.1089/end.2015.0692 10.1016/j.eururo.2015.07.040 10.1373/clinchem.2010.161547 10.1007/s002400050076 10.1016/j.cca.2021.03.017 10.1067/mem.2002.126170 10.1007/s00345-020-03509-0 10.1056/NEJMc1412853 10.1002/uog.8917 10.1007/s00467-011-2092-6 10.1111/bju.14721 10.1007/s00240-020-01217-3 10.1016/s0022-5347(17)40222-9 10.1089/end.2005.19.429 10.1007/s00467-007-0575-2 10.1007/s00467-004-1663-1 10.21037/atm.2019.07.42 10.1089/end.2019.0703 10.1016/j.ejim.2006.03.001 10.1016/s0272-6386(86)80019-1 10.1016/j.juro.2009.04.084 10.1111/j.1464-410X.2012.11352.x 10.1007/s11926-015-0510-7 10.1016/j.urology.2014.07.043 10.1016/j.bmcl.2018.03.024 10.1038/nm.4280 10.7326/0003-4819-157-6-201209180-00023 10.1007/s00345-020-03166-3
Pediatric Nephrology (Berlin, Germany); D'Ambrosio V, Capolongo G et. al.

Nov 24th, 2021 - Cystinuria is the most common genetic cause of nephrolithiasis in children. It is considered a heritable aminoaciduria as the genetic defect affects the reabsorption of cystine and three other amino acids (ornithine, lysine, and arginine) in the r...

Near-infrared Imaging Techniques for Identifying and Preserving Viable Parathyroid Glands During Thyroidectomy
https://clinicaltrials.gov/ct2/show/NCT05130476

Nov 23rd, 2021 - The most common complication after thyroidectomy is postoperative hypoparathyroidism due to unintentional intraoperative injury, excision, or devascularisation of the parathyroid glands. This complication can be either transient (≤6 months), or pe...

see more →

Guidelines  1 results

Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080344
Journal of Nephrology; Gambaro G, Croppi E et. al.

Oct 27th, 2016 - Recently published guidelines on the medical management of renal stone disease did not address relevant topics in the field of idiopathic calcium nephrolithiasis, which are important also for clinical research. A steering committee identified 27 q...

see more →

Drugs  30 results see all →

Clinicaltrials.gov  35 results

Near-infrared Imaging Techniques for Identifying and Preserving Viable Parathyroid Glands During Thyroidectomy
https://clinicaltrials.gov/ct2/show/NCT05130476

Nov 23rd, 2021 - The most common complication after thyroidectomy is postoperative hypoparathyroidism due to unintentional intraoperative injury, excision, or devascularisation of the parathyroid glands. This complication can be either transient (≤6 months), or pe...

Prospective Research Rare Kidney Stones (ProRKS)
https://clinicaltrials.gov/ct2/show/NCT02780297

Nov 11th, 2021 - Severe, hereditary forms of nephrolithiasis cause marked excretion of insoluble minerals important in stone formation, including primary hyperoxaluria, cystinuria, Dent disease, and adenine phosphoribosyltransferase deficiency (APRTd). Patients wi...

Mini-PNCL vs fURS in Management of Nephrolithiasis
https://clinicaltrials.gov/ct2/show/NCT04389853

Oct 8th, 2021 - The prevalence of nephrolithiasis is increasing over the last two decades, and kidney stones is a recurrent disorder, with lifetime recurrence risks reported to be as high as 50%. One of the most challenging stones is the lower pole (LP) nephrolit...

Search for New Genetic Causes of Hypercalcemia by Massively Parallel Sequencing of a Genes Panel
https://clinicaltrials.gov/ct2/show/NCT02908542

Aug 2nd, 2021 - Hypercalcemia, whether chronic or acute, exposes the patient to potentially serious complications (arrhythmias, nephrolithiasis, nephrocalcinosis, ...). Prevention relies primarily on effective etiological necessary for taking matched load. Under ...

Percutaneous Nephrolithotomy in Patients With Stage 2-4 Chronic Kidney Disease
https://clinicaltrials.gov/ct2/show/NCT04943081

Jun 29th, 2021 - Nephrolithiasis affects an estimated 5-10% of the general population, and this percentage continues to rise. It has a prevalence of 1.7% to 18% in patients with chronic kidney disease (CKD), and nephrolithiasis-related CKD contributed to 3.2% of t...

see more →

News  72 results

TAVI Safe and Effective in Patients With Inflammatory Bowel Disease
https://www.medscape.com/viewarticle/954929

Jul 19th, 2021 - NEW YORK (Reuters Health) - Transcatheter aortic-valve implantation (TAVI) is safe and effective for patients with inflammatory bowel disease (IBD), according to what is believed to be the first study to assess TAVI outcomes in this patient popula...

FDA Advisory Committee Votes in Favor of COVID-19 Vaccine mRNA-1273
https://www.onclive.com/view/fda-advisory-committee-votes-in-favor-of-covid-19-vaccine-mrna-1273

Dec 17th, 2020 - The FDA’s Vaccines and Related Biological Products Advisory Committee has voted 20-0 with 1 abstention to support the benefit-risk profile associated with the coronavirus disease 2019 vaccine mRNA-1273. The proposed use under the Emergency Use Au...

Combination Leflunomide-Hydroxychloroquine Promising for Sjogren's Syndrome
https://www.staging.medscape.com/viewarticle/928229

Apr 7th, 2020 - NEW YORK (Reuters Health) - A combination of two approved drugs, leflunomide and hydroxychloroquine, was safe and elicited a clinical response in a phase-2a trial for Sjogren's syndrome. For the 24-week trial, Dr. Joel Adrianus Gijsbert van Roon o...

Combination Leflunomide-Hydroxychloroquine Promising for Sjogren's Syndrome
https://www.medscape.com/viewarticle/928229

Apr 7th, 2020 - NEW YORK (Reuters Health) - A combination of two approved drugs, leflunomide and hydroxychloroquine, was safe and elicited a clinical response in a phase-2a trial for Sjogren's syndrome. For the 24-week trial, Dr. Joel Adrianus Gijsbert van Roon o...

Incidentally Discovered Ochronosis Explaining Decades of Chronic Pain
https://www.mdedge.com/fedprac/article/215093/pain/incidentally-discovered-ochronosis-explaining-decades-chronic-pain
Aaron Reyes, MD, Leila Hashemi, MD

Jan 7th, 2020 - Alkaptonuria is a rare autosomal recessive disorder uniquely known for causing black, or darkened, urine when left standing due to the renal excretion of excess homogentisic acid (HGA). When this disorder goes undiagnosed, as demonstrated in this.

see more →

Patient Education  3 results see all →